Portfolio Updates
Each month I share the key changes I make to my own portfolio, and the thinking behind them.
A running record of the changes I make to my own portfolio, published monthly.
15 July 2026
Portfolio Update (July 2026)
This month, I flagged public safety leader Axon Enterprise as high conviction, and reduced my exposure to India.
13 June 2026
Portfolio Update (June 2026)
I exited Wise over the AML investigations, started a position in Iberdrola, and began building a public-market SpaceX stake ahead of my private stock vesting.
16 May 2026
Portfolio Update (May 2026)
Started a position in Nektar Therapeutics and doubled TransMedics, exited Zscaler and Salesforce to the "too hard pile", and trimmed Rocket Lab once again on position sizing.
11 April 2026
Portfolio Update (April 2026)
Opened a starter position in Clearway Energy, exited BYD, flagged CrowdStrike and Palo Alto as high conviction, and started reporting SpaceX in my public allocations.
15 March 2026
Portfolio Update (March 2026)
Added to Amazon and MercadoLibre into weakness, and reluctantly removed the high-conviction star from Sea Ltd as its Latin American expansion struggles.
15 February 2026
Portfolio Update (February 2026)
Trimmed Rocket Lab from 15% to under 10% and put much of it into Amazon, where the warehouse automation story is what excites me. Cash up to 25%.
13 January 2026
Portfolio Update (January 2026)
Active rotation — trimmed the space winners to manage risk and redeployed into Uber, MercadoLibre and Sea, plus a new nuclear infrastructure position in Brookfield Renewable.
13 December 2025
Portfolio Update (December 2025)
Space dominated my returns as SpaceX transacted at $800bn. Trimmed Rocket Lab on risk management, preparing to trim AST SpaceMobile ahead of the BlueBird 6 launch, and revisiting nuclear via Constellation Energy.
15 November 2025
Portfolio Update (November 2025)
A spring clean — sold out of United Therapeutics, Snowflake and ASML, trimmed Alphabet and Palantir, added to MercadoLibre and started a position in Uber. Cash up to 21%.
16 October 2025
Portfolio Update (October 2025)
A significant rebalancing — trimmed Rocket Lab, Palantir and Axon on valuation and concentration, doubled Novo Nordisk, and sold out of Airtel Africa entirely.
14 September 2025
Portfolio Update (September 2025)
Tesla earns its high-conviction star back on the back of Elon's compensation plan, and I added IREN Energy and topped up Novo Nordisk after a full portfolio review on the podcast.
14 August 2025
Portfolio Update (August 2025)
Wise joins my portfolio core after five years of buying, CyberArk gets acquired by Palo Alto two weeks after I bought it, and I'm deploying cash towards a 15% target.
12 July 2025
Portfolio Update (July 2025)
Two new buys — Greggs for the income pivot, and CyberArk to rebuild my cybersecurity exposure. Tesla is no longer a high-conviction holding while Elon's politics play out.
12 June 2025
Portfolio Update (June 2025)
Cut CrowdStrike back below 3% on valuation and a couple of yellow flags, added to Amazon, and exited Remitly six months after buying it.
13 May 2025
Portfolio Update (May 2025)
Trimmed Palantir and CrowdStrike on valuation, broke my own 6% rule to add to Alphabet, and opened starter positions in Novo Nordisk and AST SpaceMobile.
15 April 2025
Portfolio Update (April 2025)
No trades in a volatile month — but I flagged Sea, NVIDIA and Nubank as high conviction, and I'm holding 25% cash while I wait for an opportunity to add.